These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34417820)

  • 1. Joint address from the President and the Chief Executive Officer of ASHP: Reflections on an unprecedented, extraordinary, and remarkable year.
    Johnson TJ; Abramowitz PW
    Am J Health Syst Pharm; 2021 Oct; 78(21):1980-1983. PubMed ID: 34417820
    [No Abstract]   [Full Text] [Related]  

  • 2. 2011 Report of the Executive Vice President and Chief Executive Officer: ASHP: continually in pursuit of truth.
    Manasse HR
    Am J Health Syst Pharm; 2011 Aug; 68(16):e62-5. PubMed ID: 21817068
    [No Abstract]   [Full Text] [Related]  

  • 3. Interview with Mama P. Borgstrom, FACHE, President and Chief Executive Officer, Yale New Haven Health System, and Chief Executive Officer, Yale-New Haven Hospital, Connecticut.
    Borgstrom MP; O'Connor SJ
    J Healthc Manag; 2014; 59(2):85-8. PubMed ID: 24783365
    [No Abstract]   [Full Text] [Related]  

  • 4. Servier in oncology: bringing innovation to patients.
    Bertrand CP
    Future Oncol; 2019 Jul; 15(19):2191-2197. PubMed ID: 31146594
    [No Abstract]   [Full Text] [Related]  

  • 5. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2014 Report of the Chief Executive Officer. ASHP is constructively dissatisfied.
    Abramowitz PW
    Am J Health Syst Pharm; 2014 Aug; 71(16):1414-7. PubMed ID: 25074966
    [No Abstract]   [Full Text] [Related]  

  • 7. Chief nursing officer to chief executive officer: lessons learned.
    Formella NA
    Nurs Adm Q; 2012; 36(1):52-9. PubMed ID: 22157790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASHP Statement on the Roles and Responsibilities of the Pharmacy Executive.
    Amerine LB; Granko RP; Brummond PW; Calabrese SV; Gullickson KK; Kelley LR; Little JD; Sullivan M
    Am J Health Syst Pharm; 2022 Mar; 79(6):497-499. PubMed ID: 34480173
    [No Abstract]   [Full Text] [Related]  

  • 9. Navigating the clinical trial pathway: Conception, design, execution, and results dissemination.
    Sampalis JS; Watson J; Boukas S; Boukas M; Harvey N; Machado S; Bordeleau M; Rampakakis E
    Surgery; 2017 Mar; 161(3):576-583. PubMed ID: 28190508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2018 Report of the Chief Executive Officer: ASHP: A powerful partnership of members, staff, and leadership focused on the unique value and expertise of pharmacists.
    Abramowitz PW
    Am J Health Syst Pharm; 2018 Aug; 75(16):1247-1250. PubMed ID: 30089674
    [No Abstract]   [Full Text] [Related]  

  • 11. 2017 Report of the Chief Executive Officer: ASHP: 75 years of leadership, innovation, and growth.
    Abramowitz PW
    Am J Health Syst Pharm; 2017 Aug; 74(16):1276-1281. PubMed ID: 28790081
    [No Abstract]   [Full Text] [Related]  

  • 12. Appendix A: Position identification, chief executive officer, president, executive director.
    Top Health Care Financ; 1980; 7(1):74-7. PubMed ID: 7434351
    [No Abstract]   [Full Text] [Related]  

  • 13. Interview With Gayle L. Capozzalo, FACHE, Executive Vice President and Chief Strategy Officer, Yale New Haven Health System, New Haven, Connecticut.
    J Healthc Manag; 2017; 62(4):225-228. PubMed ID: 28683044
    [No Abstract]   [Full Text] [Related]  

  • 14. Interview with Kevin L. Unger, FACHE, President and Chief Executive Officer, Poudre Valley Hospital Interviewed by Kyle L. Grazier.
    Unger KL
    J Healthc Manag; 2009; 54(6):357-60. PubMed ID: 20073181
    [No Abstract]   [Full Text] [Related]  

  • 15. 2020 Report of the President and the Chief Executive Officer.
    Pawlicki KS; Abramowitz PW
    Am J Health Syst Pharm; 2020 Oct; 77(21):1793-1797. PubMed ID: 32840302
    [No Abstract]   [Full Text] [Related]  

  • 16. Interview with David P. Gehant, FACHE, President and Chief Executive Officer, Boulder Community Hospital. Interview by Kyle L Grazier.
    Gehant DP
    J Healthc Manag; 2009; 54(5):287-90. PubMed ID: 19831113
    [No Abstract]   [Full Text] [Related]  

  • 17. Interview with David A. Stark, FACHE, Executive Vice President/Chief Operating Officer, Iowa Health-Des Moines. Interview by Kyle L Grazier.
    Stark DA
    J Healthc Manag; 2008; 53(5):282-6. PubMed ID: 18856133
    [No Abstract]   [Full Text] [Related]  

  • 18. 2010 Report of the Executive Vice President and Chief Executive Officer: keeping our focus during a difficult time.
    Manasse HR
    Am J Health Syst Pharm; 2010 Aug; 67(16):e43-6. PubMed ID: 20689108
    [No Abstract]   [Full Text] [Related]  

  • 19. Interview with Kenneth D. Graham, FACHE, president and chief executive officer of El Camino Hospital. Interview by Stephen J O'Connor.
    Graham KD
    J Healthc Manag; 2011; 56(4):217-21. PubMed ID: 21838019
    [No Abstract]   [Full Text] [Related]  

  • 20. Interview with Kimberly A. Russel, FACHE, President and Chief Executive Officer, BryanLGH Health System. Interview by Kyle A Grazier.
    Russel KA
    J Healthc Manag; 2009; 54(3):147-9. PubMed ID: 19554794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.